1. Home
  2. CNDT vs NNNN Comparison

CNDT vs NNNN Comparison

Compare CNDT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$1.50

Market Cap

234.2M

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$3.61

Market Cap

163.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNDT
NNNN
Founded
2016
2021
Country
United States
Germany
Employees
51000
N/A
Industry
Business Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.2M
163.7M
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
CNDT
NNNN
Price
$1.50
$3.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 915.3K
51.5K
Earning Date
11-06-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $3,042,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$446.57
Revenue Growth
N/A
★ N/A
52 Week Low
$1.15
$3.09
52 Week High
$2.63
$44.73

Technical Indicators

Market Signals
Indicator
CNDT
NNNN
Relative Strength Index (RSI) 44.95 32.29
Support Level $1.31 $3.09
Resistance Level $1.62 $6.95
Average True Range (ATR) 0.08 0.53
MACD -0.01 -0.00
Stochastic Oscillator 37.50 25.50

Price Performance

Historical Comparison
CNDT
NNNN

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: